Non-PCOS Non-PCOS PCOS PCOS
(N=23708) (N=23708) (N=5927) (N=5927)
Variables n % n % p-value
Age, year 1.00
20-30 14160 60% 3540 60%
31-40 8165 34% 2043 34%
41-50 1383 6% 344 6%
mean, (SD) 29.3 (6.19) 29.1 (6.01) 0.06
Comorbidities
asthma 1066 4% 332 6% <0.001
anxiety 70 0.30% 27 0.46% 0.07
CAD 179 1% 58 1% 0.10
cancer 87 0.37% 14 0.24% 0.16
COPD 2617 11% 798 13% <0.001
CHF 41 0.17% 19 0.32% 0.04
CLD 1309 6% 492 8% <0.001
diabetes 314 1% 170 3% <0.001
depression 1062 4% 361 6% <0.001
hypertension 390 2% 171 3% <0.001
hyperlipidemia 624 3% 338 6% <0.001
stroke 162 1% 55 1% 0.06
sleep apnea 34 0.14% 19 0.32% 0.01
CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; CHF: congestive heart failure; CLD: chronic liver diseases; Follow-up time: Control: 6.76(3.56) Case: 6.80(3.56) CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; CHF: congestive heart failure; CLD: chronic liver diseases; Follow-up time: Control: 6.76(3.56) Case: 6.80(3.56) CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; CHF: congestive heart failure; CLD: chronic liver diseases; Follow-up time: Control: 6.76(3.56) Case: 6.80(3.56) CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; CHF: congestive heart failure; CLD: chronic liver diseases; Follow-up time: Control: 6.76(3.56) Case: 6.80(3.56) CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; CHF: congestive heart failure; CLD: chronic liver diseases; Follow-up time: Control: 6.76(3.56) Case: 6.80(3.56) CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; CHF: congestive heart failure; CLD: chronic liver diseases; Follow-up time: Control: 6.76(3.56) Case: 6.80(3.56) CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; CHF: congestive heart failure; CLD: chronic liver diseases; Follow-up time: Control: 6.76(3.56) Case: 6.80(3.56)